| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
PRLR |
PRLR: Prolactin receptor precursor |
1.132 |
Evidence |
|
| ADORA1 |
ADORA1: Adenosine receptor A1 |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
1.132 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
1.132 |
Evidence |
|
| EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
1.132 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
1.132 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.132 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
1.132 |
Evidence |
|
| RGS4 |
RGS4: Regulator of G-protein signaling 4 |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
1.132 |
Evidence |
|
| RGS5 |
RGS5: Regulator of G-protein signaling 5 |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
1.132 |
Evidence |
|
| ADAMTS4 |
ADAMTS4, KIAA0688, UNQ769/PRO1563: ADAMTS-4 precursor |
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
1.132 |
Evidence |
|
| MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
1.132 |
Evidence |
|
| EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.132 |
Evidence |
|
| MAX |
MAX: Protein max |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
1.132 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
1.132 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
1.132 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
1.132 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SYK |
SYK: Tyrosine-protein kinase SYK |
1.132 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
1.132 |
Evidence |
|
| PHC2 |
PHC2, EDR2, PH2: Polyhomeotic-like protein 2 |
SCML2 |
SCML2: Sex comb on midleg-like protein 2 |
1.132 |
Evidence |
|